This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Oral contraceptive (long term effects)

Authoring team

25 year follow-up of cohort of 46000 women from Royal College of General Practitioners' oral contraception study

  • 25 year cohort study
  • data from 46000 women
  • the mortality in women who had ever used the pill was compared with never use, allowing for use and time elapsed since last use
  • the study found that mortality from cerebrovascular and circulatory disease was greater in current and recent pill users. The mortality from colon and ovarian cancer was lower in current and recent pill users. After 10 years or more more after cessation of pill use, the mortality in never users and past users was similar.

Collaborative Group on Hormonal Factors in Breast Cancer

  • collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
  • found a slight increase in breast cancer in current and recent pill users but no excess deaths 10 years after cessation

Reference:

  • BMJ (1999), 318, 96-100.
  • Lancet (1996), 347, 1713-27.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.